Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 30,031 | 7,005 | 4,966 | 9,992 | 4,670 |
| Other current assets | 0 | 67 | 142 | 73 | 330 |
| TOTAL | $30,353 | $7,165 | $5,243 | $10,647 | $5,000 |
| Non-Current Assets | |||||
| PPE Net | 37 | 36 | 13 | 34 | 80 |
| Intangibles | 0 | 93 | 191 | 289 | 0 |
| Other Non-Current Assets | 33 | 0 | 0 | 86 | 460 |
| TOTAL | $70 | $129 | $204 | $409 | $540 |
| Total Assets | $30,423 | $7,294 | $5,447 | $11,056 | $5,560 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 335 | 476 | 416 | 261 | 450 |
| Accrued Expenses | 861 | 433 | 181 | 1,133 | 2,750 |
| TOTAL | $1,419 | $1,251 | $901 | $2,259 | $3,210 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 7,610 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $7,610 |
| Total Liabilities | $1,419 | $1,251 | $901 | $2,259 | $10,820 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 26,545 | 15,236 | 2,056 | N/A | 579 |
| Common Shares | 207 | 56 | 17 | 13 | 50 |
| Retained earnings | -251,155 | -238,508 | -225,432 | -217,353 | -207,700 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 10 |
| TOTAL | $29,004 | $6,043 | $4,546 | $8,797 | $-5,250 |
| Total Liabilities And Equity | $30,423 | $7,294 | $5,447 | $11,056 | $5,570 |